Reader
Reusable electronics interrogate the sensing component and measure signals. Device configuration and readiness require product-specific confirmation.
THE PLATFORM CONCEPT
From molecular recognition
to a measurable signal.
The technology concept combines target-specific molecular recognition with graphene field-effect transistor sensing. An electrical response is one part of a complete assay—not proof of diagnostic readiness.
HOW THE CONCEPT WORKS
Seven steps. One assay-specific pathway.
Biomarker
Define the biological target or measurable indicator relevant to the intended question.
Recognition element / aptamer
Select a molecular recognition element intended to bind the target.
Molecular binding
The target interacts with the recognition chemistry under defined test conditions.
GFET sensing
A graphene field-effect transistor senses binding-related changes.
Electrical signal
The sensor response is measured electronically.
Signal processing
Reader electronics and assay-specific processing evaluate the measured response.
Interpreted result
Calibration, controls and validation determine what the signal can mean for the intended use.
The workflow is conceptual. Sample compatibility, performance, interpretation, authorization and availability depend on the exact assay and market.
THE TECHNOLOGY LAYERS
A platform is more than a sensor.
Cartridge / consumable
An application-specific disposable component can bring recognition chemistry and sample handling into the assay workflow. Its design and availability are assay-specific.
Assay
The complete test includes target, recognition chemistry, sample handling, calibration, controls, interpretation and validation.
Software / data layer
A software/data layer is part of the working platform model. Specific connectivity and analytics functions are not presented here as implemented products.
READINESS MATTERS
Different evidence. Different claims.
- Platform technology
- A sensing approach or architecture. It does not establish every proposed assay.
- Research demonstration
- Evidence for an exact target, sample and experimental setting; findings cannot be generalized beyond the source.
- Validated assay
- A complete test with evidence supporting a defined analytical or clinical validation scope.
- Commercial availability
- Confirmed supply for a specified offering and geography; separate from scientific plausibility.
- Regulatory authorization
- Documented authorization for the jurisdiction and intended use. It is not interchangeable with research validation.
This page explains the framework. It does not list any assay as validated, commercially available or regulator-authorized. The platform is not presented as a replacement for every laboratory discipline.
Explore a scientific collaboration.
Tell us your target, sample context and intended use so the relevant readiness questions can be considered.